Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Rocío Pérez-Iglesias, MD, PhD
JCP
Original Research
A 12-Week Randomized Clinical Trial to Evaluate Metabolic Changes in Drug-Naive, First-Episode Psychosis Patients Treated With Haloperidol, Olanzapine, or Risperidone
November 15, 2007
Rocío Pérez-Iglesias
,
Benedicto Crespo-Facorro
,
Jose Antonio Amado
, et al
JCP
Original Research
A Practical Clinical Trial Comparing Haloperidol, Risperidone, and Olanzapine for the Acute Treatment of First-Episode Nonaffective Psychosis.
October 16, 2006
Benedicto Crespo-Facorro
,
Rocío Pérez-Iglesias
,
MariLuz Ramirez-Bonilla
, et al
JCP
Original Research
Attenuation of Antipsychotic-Induced Weight Gain With Early Behavioral Intervention in Drug-Naive First-Episode Psychosis Patients: A Randomized Controlled Trial
August 15, 2006
Mario Álvarez-Jiménez
,
Cesar González-Blanch
,
Jose Luis Vázquez-Barquero
, et al
